Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan (Atc Code: G04Bx21)

AOK PLUS - Die Gesundheitskasse fur Sachsen und Thuringen Germany has Released a tender for Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan (Atc Code: G04Bx21) in Pharmaceuticals. The tender was released on Jul 04, 2024.

Country - Germany

Summary - Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan (Atc Code: G04Bx21)

Deadline - Aug 31, 2026

GT reference number - 83630773

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 83630773

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan (Atc Code: G04Bx21)local title:: Abschluss nicht exkl. Arzneimittel-Raba ttvereinb. nach ยง 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tolvaptan (ATC-Code: G04BX21)

Gt Ref Id - 83630773

Deadline - Aug 31, 2026

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database